Distribution of dopamine D3 receptor expressing neurons in the human forebrain comparison with D2 receptor expressing neurons

Neuropsychopharmacology

Volumn 20, Issue 1, 1999, Pages 60-80

  Gurevich, Eugenia V ^a   Joyce, Jeffrey N ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Dopamine D2 receptor; Dopamine D3 receptor; Human brain; Nonisotopic in situ hybridization; Receptor binding

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; MESSENGER RNA; DRD3 PROTEIN, HUMAN;

AMYGDALOID NUCLEUS; ARTICLE; BINDING SITE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; FOREBRAIN; GLOBUS PALLIDUS; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYPOTHALAMUS; NORMAL HUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR BINDING; SUBSTANTIA NIGRA; THALAMUS; THALAMUS NUCLEUS; AGED; BASAL GANGLION; COMPARATIVE STUDY; FEMALE; IN VITRO STUDY; LIMBIC SYSTEM; MALE; METABOLISM; NERVE CELL; TISSUE DISTRIBUTION; VENTRAL TEGMENTUM;

AGED; AMYGDALA; BASAL GANGLIA; FEMALE; HUMANS; HYPOTHALAMUS; LIMBIC SYSTEM; MALE; NEURONS; PROSENCEPHALON; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RNA, MESSENGER; SUBSTANTIA NIGRA; THALAMUS; TISSUE DISTRIBUTION; VENTRAL TEGMENTAL AREA;

EID: 0032589813     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00066-9     Document Type: Article

References (74)

1. Aggleton J.P. The functional effects of amygdala lesions in humans. A comparison with findings from monkeys Aggleton J.P. The Amygdala. Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction:1992;485-503 Wiley-Liss, New York, NY.
2. Albrecht D., Quäschling U., Zippel U., Davidowa H. Effects of dopamine on neurons of the LGN. An ionophoretic study Synapse. 23:1996;70-78.
3. Alheid G.F., Heimer L., Switzer R.C. III Basal ganglia. Paxinos G. The Human Nervous System. 1990;483-583 Academic Press, San Diego.
4. Armstrong E. Enlarged limbic structures in the human brain. The anterior thalamus and medial mamillary body Brain Res. 362:1986;394-397.
5. Armstrong E. Limbic thalamus. Anterior and mediodorsal nuclei Paxinos G. The Human Nervous System. 1990;469-483 Academic Press, San Diego.
6. 125I]iodosulpride. Neuroscience. 20:1987;117-155.
7. Bouthenet M.-L., Souil E., Martres M.-P., Sokoloff P., Giros B., Schwartz J.-C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry. Comparison with dopamine D2 receptor mRNA Brain Res. 564:1991;203-219.
8. Bungener C., Jouvent R., Derouesne C. Affective disturbances in Alzheimer's disease. J Am Geriatr Soc. 44:1996;1066-1071.
9. Cadieux N.L., Greve K.W. Emotion processing in Alzheimer's disease. J Int Neuropsychol. 3:1997;411-419.
10. Caine S.B., Koob G.F. Modulation of cocaine self-administration in the rat through D3 dopamine receptors. Science. 260:1993;1814-1816.
11. Carlsson M., Carlsson A. Schizophrenia. a subcortical neurotransmitter imbalance syndrome Schizophr Bull. 16:1990;425-432.
12. Choi W.S., Machida C.A., Ronnekleiv O.K. Distribution of dopamine D1, D2, and D5 receptor mRNAs in the monkey brain. Ribonuclease protection assay analysis Mol Brain Res. 31:1995;86-94.
13. Diaz J., Lévesque D., Lammers C.H., Griffon N., Martres M.-P., Schwartz J.-C., Sokoloff P. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience. 65:1995;731-745.
14. François C., Yelnik J., Percheron G. Golgi study of the primate substantia nigra. II. Spatial organization of dendritic arborization in relation to the cytoarchitectonic boundaries and to the striatonigral bundle. J Comp Neurol. 265:1987;473-493.
15. Gaykema R.P., Zaborszky L. Direct catecholaminergic-cholinergic interaction in the basal forebrain. II. Substantia nigra-ventral tegmental area projection to cholinergic neurons. J Comp Neurol. 374:1996;555-577.
16. Groenewegen H.J., Berendse H.W., Wolters J.G., Lohman A.H. The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala. Evidence for a parallel organization Prog Brain Res. 85:1990;95-116.
17. Gurevich E.V., Joyce J.N. Distribution of dopamine (DA) D3 receptor mRNA and D2 receptor mRNA in the human forebrain. Soc Neurosci Abstr. 22:1996;1581.
18. Gurevich E.V., Bordelon Y., Shapiro R.M., Arnold S.E., Gur R.E., Joyce J.N. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study Arch General Psychiatry. 54:1997;225-232.
19. Haber S.N., Groenewegen H.J., Grove E.A., Nauta W.J. Efferent connections of the ventral pallidum. evidence of a dual striato pallidofugal pathway J Comp Neurol. 235:1985;322-335.
20. Haber S.N., Groenewegen J.H. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia nigra. J Comp Neurol. 290:1989;53-68.
21. Haber S.N., Lynd-Balta E., Spooren W.P.J.M. Integrative aspects of basal ganglia circuitry. Adv Beh Biol. 41:1994;71-80.
22. Haber S.N., Fudge J.L. The primate substantia nigra and VTA. Integrative circuitry and function Critical Rev Neurobiol. 11:1997;323-342.
23. Heckers S., Geula C., Mesulam M.-M. Cholinergic innervation of the human thalamus. Dual origin and differential nuclear distribution J Comp Neurol. 325:1992;68-82.
24. 3H] 7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res. 648:1994;222-228.
25. Huang Q., Zhou D., Chase K., Gusella J.F., Aronin N., DiFiglia M. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc Nat Acad Sci. 89:1992;11988-11992.
26. Huntley G.W., Morrison J.H., Prikhozhan A., Sealfon S.C. Localization of multiple dopamine receptor subtype mRNA in human and monkey motor cortex and striatum. Mol Brain Res. 15:1992;181-188.
27. Hurd Y.L., Pristupa Z.B., Herman M.M., Niznik H.B., Kleinman J.E. The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience. 63:1994;357-362.
28. Ilinsky I.A., Jouandet M.R., Goldman-Rakic P.S. Organization of the nigrothalamocortical system in the rhesus monkey. J Comp Neurol. 236:1985;315-330.
29. Janowski A., Neve K.A., Kinzie J.M., Taylor B., de Paulis T., Belkmar J.K. Extrastriatal dopamine D2 receptors. Distribution, pharmacological characterization and region-specific regulation by clozapine J Pharmacol Exp Ther. 261:1992;1282-1290.
30. Jimenez-Castellanos J., Graybiel A.M. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience. 23:1987;223-242.
31. Jones E.G. Correlation and revised nomenclature of ventral nuclei in the thalamus of human and monkey. Stereotact Funct Neurosurg. 54, 55:1990;1-20.
32. Joyce J.N., Sapp D.W., Marshall J.F. Human striatal dopamine receptors were organized in patches. Proc Natl Acad Sci USA. 83:1986;8002-8006.
33. 125I]Epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. J Pharmacol Exp Ther. 253:1991;1253-1263.
34. Joyce J.N., Kaeger C., Ryoo H., Goldsmith S. Dopamine D2 receptors in the hippocampus and amygdala in Alzheimer's disease. Neurosci Lett. 154:1993;171-174.
35. Joyce J.N., Meador-Woodruff J.H. Linking the family of D2 receptors to neuronal circuits in human brain. Insights into schizophrenia Neuropsychopharmacology. 16:1997;375-384.
36. 125I] epidepride. Brain Res. 609:1993;237-243.
37. Kultas-Ilinsky K., Ilinsky I.A. Fine structure of the magnocellular subdivision of the ventral anterior thalamic nucleus (Vamc) of Macaca mulatta. II. Organization of nigrothalamic afferents as revealed with EM autoradiography J Comp Neurol. 294:1990;479-489.
38. Kunishio K., Haber S.N. The primate striatal projections from the amygdala and hippocampus. A retrograde study Soc Neurosci Abstr. 20:1994;333.
39. Landwehrmeyer B., Mengold G., Palacios J.M. Dopamine D3 receptor mRNA and binding sites in human brain. Mol Brain Res. 18:1993;187-192.
40. 2 dopamine receptors Neuroscience. 73:1996;131-143.
41. Lévesque D., Martres M.-P., Diaz J., Griffon N., Lammers C.H., Sokoloff P., Schwartz J.-C. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci USA. 92:1995;1719-1723.
42. Lynd-Balta E., Haber S.N. The organization of midbrain projections to the ventral striatum in the primate. Neuroscience. 59:1994;609-623. a.
43. Lynd-Balta E., Haber S.N. Primate striatonigral projections. A comparison of the sensorimotor-related striatum and the ventral striatum J Comp Neurol. 345:1994;562-578. b.
44. Malais P., Waltregny A., Maula A., Dresse A. Dopamine and acetylcholine release in thalamus of non-parkinsonian and parkinsonian subjects. Acta Neurol Belg. 90:1990;200-206.
45. Marchand R., Lajoie L. Histogenesis of the striopallidal system in the rat. Neuroscience. 17:1986;573-590.
46. Marchand R., Lajoie L., Lanchet C. Histogenesis at the level of the basal forebrain. The entopeduncular nucleus Neuroscience. 17:1986;591-607.
47. Meador-Woodruff J.H., Mansour A., Healy D.J., Kuehn R., Zhou Q.Y., Bunzow J.R., Akil H., Civelli O., Watson S.J. Jr. Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology. 5:1991;231-242.
48. Meador-Woodruff J.H., Damask S.P., Watson S.J. Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc Nat Acad Sci USA. 91:1994;8297-8301. a.
49. Meador-Woodruff J.H., Grandy D.K., Van Tol H.H.M., Damask S.P., Little K.Y., Civelli O., Watson S.J. Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology. 10:1994;239-248. b.
50. Meador-Woodruff J.H., Damask S.P., Wang J., Haroutunian V., Davis K.L., Watson S.J. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology. 15:1996;17-29.
51. Murray A.M., Ryoo H., Gurevich E.V., Joyce J.N. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Nat Acad Sci USA. 91:1994;11271-11275.
52. Nissbrandt H., Ekman A., Eriksson E., Heilig M. Dopamine D3 receptor antisense influences dopamine synthesis in rat brain. NeuroReport. 6:1995;573-576.
53. Ohye C. Thalamus. Paxinos G. The Human Nervous System. 1990;439-469 Academic Press, San Diego.
54. Oke A.F., Putz C., Adams R.N., Bird E.D. Neuroleptic treatment was an unlikely cause of elevated dopamine in thalamus of schizophrenic subjects. Psychiatry Res. 45:1992;203-208.
55. de Olmos J. Amygdaloid nuclei gray complex. Paxinos G. The Human Nervous System. 1990;583-711 Academic Press, San Diego.
56. Papadopoulus G.C., Parnavelas J.G. Distribution and synaptic organization of dopaminergic axons in the lateral geniculate nucleus of the rat. J Comp Neurol. 294:1990;356-361.
57. Paxinos G., Tork I., Halliday G., Mehler W. Human homologs to brainstem nuclei identified in other animals as revealed by acetylcholinesterase activity. Paxinos G. The Human Nervous System. 1990;149-203 Academic Press, San Diego.
58. Rivet J.-M., Audinot V., Gobert A., Peglion J.-L., Millan M.J. Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+) -S 14297. Eur J Pharmacol. 265:1994;175-177.
59. Sadikot A.F., Parent A. The monoaminergic innervation of the amygdala in the squirrel monkey. An immunohistochemical study Neuroscience. 36:1990;431-447.
60. Saper CB (1990): Hypothalamus. In Paxinos G (ed), The Human Nervous System. San Diego Academic Press, pp 389-415.
61. Sibley D.R., Monsma F.J., Shen Y. Molecular neurobiology of D1 and D2 dopamine receptors. Waddington J.L. Neuroscience and Psychopharmacology. D1:D2 Dopamine Receptor Interactions:1993;1-21 Academic Press, San Diego.
62. Sims K.S., Williams R.S. The human amygdaloid complex. A cytologic and histochemical atlas using Nissl, acetylcholinesterase and nicotinamid adenine dinucleotide phosphate diaphorase staining Neuroscience. 36:1990;449-472.
63. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:1990;146-151.
64. Sokoloff P., Schwartz J.-C. Novel dopamine receptors half a decade later. TIPS. 16:1995;270-275.
65. Staley J.K., Mash D.C. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci. 16:1996;6100-6106.
66. Surmeier D.J., Wen-Jie S., Zhen Y. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci. 16:1996;6579-6591.
67. Suzuki M., Hurd Y.L., Sokoloff P., Schwartz J.-C., Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 779:1998;58-74.
68. Takada M. The A11 catecholamine cell group. another origin of the dopaminergic innervation of the amygdala Neurosci Lett. 118:1990;132-135.
69. Torack R.M., Morris J.C. The association of ventral tegmental area histopathology with adult dementia. Arch Neurol. 45:1988;497-501.
70. von Cramon D.Y., Hebel N., Schuri U. A contribution to the anatomical basis of thalamic amnesia. Brain. 108:1985;993-1008.
71. Yelnik J., François C., Percheron G., Heyner S. Golgi study of the primate substantia nigra. I. Quantitative morphology and typology of nigral neurons. J Comp Neurol. 265:1987;455-472.
72. Zaborszky L., Cullianan W.E. Direct catecholaminergic-cholinergic interactions in the basal forebrain. I. Dopamine-beta-hydroxylase- and tyrosine hydroxylase input to cholinergic neurons. J Comp Neurol. 374:1996;534-554.
73. Zaborszky L., Cullinan W.E., Luiine V.N. Catecholaminergic-cholinergic interaction in the basal forebrain. Prog Brain Res. 98:1993;31-49.
74. Zahm D.S., Brog J.S. On the significance of subterritories in the "accumbens" part of the ventral striatum. Neuroscience. 50:1992;751-767.